Citius Pharmaceuticals (CTXR) Other financing activities (2014 - 2026)

Citius Pharmaceuticals (CTXR) has reported Other financing activities for 11 consecutive years, with $9.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities changed N/A year-over-year to $9.6 million; the trailing twelve-month figure through Jun 2026 stood at $15.7 million (changed N/A YoY), and the FY2024 full-year result was $13.8 million, changed 0.04% from the prior year.
• Other financing activities improved to $9.6 million in Q2 2026 per CTXR's latest filing, from $3.5 million in the prior quarter.
• Across five years, Other financing activities topped out at $13.8 million in Q2 2023 and bottomed at -$687.0 in Q3 2023.
• Historically, Other financing activities has averaged $4.9 million across 4 years, with a median of $3.0 million in 2024.
• The widest YoY moves for Other financing activities: up 12433.77% in 2024, down 12433.77% in 2024.
• Over 4 years, Other financing activities stood at -$687.0 in 2023, then soared by 374779.91% to $2.6 million in 2024, then jumped by 34.64% to $3.5 million in 2025, then jumped by 175.89% to $9.6 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $9.6 million, $3.5 million, and $2.6 million for Q2 2026, Q1 2025, and Q4 2024 respectively.